Clinical Trial

Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 23, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of SHR-4597 inhalants in adults with asthma: a multicenter, randomized, open-label, positive-controlled Phase II clinical study
Trial Details
NCT Number NCT06940700
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Asthma
Enrollment 60 participants
Start Date 2025-04
Primary Completion 2025-10 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-23